With the analysis among 1,363 patents, we discovered top 475 key players by total patent application. Boehringer Ingelheim International GmbH, Sigma-Tau Industrie Farmaceutiche Riunite SpA, Sanofi-Aventis Deutschland GmbH are dominant in this area. They take 8.66% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 47
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 33
Indiana, United States
Patent: 30
Pennsylvania, United States
Patent: 25
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 22
F. Hoffmann-La Roche Ltd.
The Institutes for Pharmaceutical Discovery, Inc.
Connecticut, United States
Patent: 19
Rhode Island, United States
Patent: 18
Basel-Stadt, Switzerland
Patent: 16
With the analysis among 27 patents, we discovered top 9 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, I2o Therapeutics, Inc., SyntheX, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Massachusetts, United States
Patent: 5
California, United States
Patent: 4
Galvani Bioelectronics Ltd.
Herefordshire, United Kingdom
Patent: 4
Intarcia Therapeutics, Inc.
California, United States
Patent: 1
California, United States
Patent: 1
Accessible Diagnostics LLC
South Carolina, United States
Patent: 1
California, United States
Patent: 1
With the analysis among related 684 patents applied in the last 5 years. We discover 326 most active companies in this area. The fast-growing Eli Lilly & Co., MedImmune Ltd., Regeneron Pharmaceuticals, Inc. take 6.87% of patent filing during this period.
Indiana, United States
Patent: 21
Cambridgeshire, United Kingdom
Patent: 13
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 13
Jiangsu Hansoh Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 12
Rhode Island, United States
Patent: 12
Louisiana, United States
Patent: 12
Jiangsu Sheng, China
Patent: 11
Shanghai Hansoh Biomedical Co. Ltd.
Shanghai Shi, China
Patent: 10
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 9
Centre National De La Recherche Scientif
With the analysis among related 684 patents in last 5 years, we discover 267 new entrants. MedImmune Ltd., Jiangsu Hansoh Pharmaceutical Co. Ltd., MedImmune LLC are the most active new entrants in this area.
Cambridgeshire, United Kingdom
Patent: 13
Jiangsu Hansoh Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 12
Louisiana, United States
Patent: 12
Jiangsu Sheng, China
Patent: 11
Shanghai Hansoh Biomedical Co. Ltd.
Shanghai Shi, China
Patent: 10
New York, United States
Patent: 7
California, United States
Patent: 6
Zuid-Holland, Netherlands
Patent: 5
With the analysis among 295 patents, we discovered top 105 universities and scientific research institutions by total patent application. Jiangnan University, Baylor College of Medicine, President & Fellows of Harvard College are dominant in this area. They take 9.83% of the total patent filing.
Jiangsu Sheng, China
Patent: 11
Baylor College of Medicine
Texas, United States
Patent: 8
President & Fellows of Harvard College
Massachusetts, United States
Patent: 8
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 7
The Salk Institute for Biological Studies
California, United States
Patent: 6
Connecticut, United States
Patent: 5
The Scripps Research Institute
California, United States
Patent: 5
Gansu Sheng, China
Patent: 4
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 4